Outsourcing medical services provider ICON has reported revenues of $120.7m, a 40% jump on the same quarter last year.
Income from operations, on a US GAAP basis, was $12.6m and net profit was $10.1m or 35 cents per share, on a diluted basis.
The company said that adjusted income from operations increased by 63% to $13.6m and adjusted diluted earnings per share increased by 65% for the third quarter to 38 cents.
ICON also said it had invited tenders for the sale & leaseback of its Dublin facility, which is currently undergoing a €60m expansion.
Chairman John Climax said Icon's clinical business continues to grow and market conditions remain positive.
Icon provides outsourced development services to the pharmaceutical, biotechnology and medical device industries.
